Precision Molecular Pathology of Aggressive B-Cell Lymphomas
Produktnummer:
18d33211819c974dc68a8e6208e85cb4d5
Themengebiete: | Burkitt Lymphoma Epstein-Barr Virus Lymphoproliferative Disease Next Generation Sequencing Primary Mediastinal Large B cell Lymphoma Primary central nervous system Lymphoma |
---|---|
Veröffentlichungsdatum: | 15.02.2024 |
EAN: | 9783031468414 |
Sprache: | Englisch |
Seitenzahl: | 438 |
Produktart: | Gebunden |
Herausgeber: | Crane, Genevieve M. Loghavi, Sanam |
Verlag: | Springer International Publishing |
Produktinformationen "Precision Molecular Pathology of Aggressive B-Cell Lymphomas"
Written by experts in the field, Precision Molecular Pathology of Aggressive B-Cell Lymphomas contains the most recent revisions from the 5th Edition WHO and 2022 International Consensus Classification diagnostic categories and serves as an important resource for trainees, pathologists, haematologist/oncologists, other clinicians involved in lymphoma care and lymphoma researchers. It provides a comprehensive yet concise synthesis of emerging molecular advances that inform patient care and improve understanding of disease mechanisms. In addition, it provides the necessary background to how molecular techniques are performed to enable the reader to better interpret and critically evaluate relevant and emerging data. As part of the Molecular Pathology Library series, this book focuses specifically on aggressive B-cell lymphomas given the increasing relevance of molecular data for diagnosis and treatment of these disorders. This evidence-based text contains 25 chapters and is divided into 5 parts. Part 1 provides a brief history and background of aggressive B-cell lymphomas. Landmark events in their classification and treatment are given in order to place the substantial advances in the field in context. Part 2 reviews molecular pathology methods, including the increasing use of next generation sequencing techniques in clinical practice. Parts 3 and 4 focus on individual subtypes of aggressive B-cell lymphoma, including a summary of the diagnostic criteria and key pathologic and clinical features for each entity. Finally, Part 5 focuses on emerging molecular technologies that may significantly impact clinical practice.

Sie möchten lieber vor Ort einkaufen?
Sie haben Fragen zu diesem oder anderen Produkten oder möchten einfach gerne analog im Laden stöbern? Wir sind gerne für Sie da und beraten Sie auch telefonisch.
Juristische Fachbuchhandlung
Georg Blendl
Parcellistraße 5 (Maxburg)
8033 München
Montag - Freitag: 8:15 -18 Uhr
Samstags geschlossen